Katherine Eban

Some years ago, I began hearing from my sources that I should investigate the generic drug industry. A generic drug boom was underway and it had led to a gold-rush mentality, they said. There seemed no good way into this nebulous topic, and no way to assess the actual quality of U.S. generic drugs.